Glaucoma:

Indications for DURYSTA:

Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.

Adult:

See full labeling. Perform intracameral inj procedure under magnification as directed.

Children:

Not established.

Contraindications:

Ocular or periocular infections. Corneal endothelial cell dystrophy (eg, Fuchs' Dystrophy). Prior corneal transplantation or endothelial cell transplants (eg, Descemet's Stripping Automated Endothelial Keratoplasty). Absent or ruptured posterior lens capsule.

Warnings/Precautions:

Limited corneal endothelial cell reserve. Narrow iridocorneal angles (Shaffer grade <3). Anatomical obstruction (eg, scarring). Aphakia. Pseudophakia with torn posterior lens capsule. Risk factors for macular edema. Active intraocular inflammation (eg, uveitis). Increased iris pigmentation: evaluate regularly. Endophthalmitis. Pregnancy. Nursing mothers.

Pharmacologic Class:

Prostaglandin analogue.

Adverse Reactions:

Conjunctival hyperemia, foreign body sensation, eye pain/irritation, photophobia, conjunctival hemorrhage, dry eye, intraocular pressure increased, corneal endothelial cell loss, vision blurred, iritis, headache.

Generic Availability:

NO

How Supplied:

Implant—1 (w. applicator)

Pricing for DURYSTA

10mcg implant (Qty: 1)
Appx. price $1999
GoodRx